Nano-oncology revisited: Insights on precise therapeutic advances and challenges in tumor

The integration of nanotechnology with cancer therapy has revolutionized traditional diagnostic and treatment methods, giving rise to the new interdisciplinary field of nano-oncology. With advancements in scientific research and ongoing technological innovations, nano-oncology is expected to play an increasingly critical role in future cancer therapies. However, the clinical translation of nanomedicines still faces several challenges, including the interaction of nanoparticles with biological systems, effective accumulation at tumor sites, and the precise fabrication of therapeutic agents. This review focuses on the challenges and future directions in nano-oncology research, with a specific emphasis on multi-stage targeting strategies and the application of artificial intelligence. The aim is to provide insights into the development of individualized nanomedicine approaches and contribute to advancing the field of nano-oncology.

Authors

Institutions

Publication Details

Journal
Fundamental Research
Published
2025-05-14
DOI
https://doi.org/10.1016/j.fmre.2025.03.024
Citations
9
Primary Topic
Nanoparticle-Based Drug Delivery
Type
article
Field-Weighted Citation Impact
5.37
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Nano-oncology revisited: Insights on precise therapeutic advances and challenges in tumor

Gang Yao, Lesheng Teng, Ye Bi, Xiaofang Xing
9 citations
Fundamental Research
Nanoparticle-Based Drug Delivery
5.37
article

Nano-oncology revisited: Insights on precise therapeutic advances and challenges in tumor

Gang Yao, Lesheng Teng, Ye Bi, Xiaofang Xing
article en
9 citations

Abstract

The integration of nanotechnology with cancer therapy has revolutionized traditional diagnostic and treatment methods, giving rise to the new interdisciplinary field of nano-oncology. With advancements in scientific research and ongoing technological innovations, nano-oncology is expected to play an increasingly critical role in future cancer therapies. However, the clinical translation of nanomedicines still faces several challenges, including the interaction of nanoparticles with biological systems, effective accumulation at tumor sites, and the precise fabrication of therapeutic agents. This review focuses on the challenges and future directions in nano-oncology research, with a specific emphasis on multi-stage targeting strategies and the application of artificial intelligence. The aim is to provide insights into the development of individualized nanomedicine approaches and contribute to advancing the field of nano-oncology.

Fundamental ResearchVol. 5(5)
National Natural Science Foundation of China (CN), Jilin University (CN), Peking University (CN), Peking University Cancer Hospital (CN), Changchun University of Chinese Medicine (CN)
Openalex Percentile: Top 4%
Nanoparticle-Based Drug Delivery
5.37
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Nano-oncology revisited: Insights on precise therapeutic advances and challenges in tumor — Gang Yao, Lesheng Teng, et al. · Fundamental Research (2025) | TGRS Research Map | TGRS